Thoracic Aortic Aneurysm
45
13
20
11
Key Insights
Highlights
Success Rate
85% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
4.4%
2 terminated out of 45 trials
84.6%
-1.9% vs benchmark
4%
2 trials in Phase 3/4
45%
5 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (45)
Post Market Registry for GORE® TAG® Thoracic Branch Endoprosthesis
Cerebral Hemodynamics and Microemboli During Placement of Relay®Branch Thoracic Stent-Graft System
HEART: Pilot Randomized Controlled Trial
MBA Early Feasibility Study
Incidence of Major Complication in Case of Thoracic Aortic Aneurysm
Terumo Aortic Global Endovascular Registry
Zenith Thoracic Alpha (ZTA) Post-Market Data Collection
Pathogenetic Basis of Aortopathy and Aortic Valve Disease
Thoraflex Hybrid and Relay Extension Post-Approval Study
Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients
B-SAFER: Branched Stented Anastomosis Frozen Elephant Trunk Repair
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used as a Bridging Stent With Branched and Fenestrated Endografts in the Treatment of Aortic Aneurysms Involving the Renal-Mesenteric Arteries
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
Effects of Exercise on Thoracic Aneurysms
Impact of Right Atrial Occlusion on TEVAR Outcomes
Genetic Architecture of Acute Aortic Syndromes and Aortic Aneurysm.
Active Thoracic Compromised Distal LANding in TEvar
Mid- and Long-term Outcomes of Custom-made Aortic Devices
CTAG Dissection/Trauma Post Marketing Surveillance Japan
AOrtic Surgery: Systemic Inflammatory Response Versus Sepsis